Manufacturer record
Mercury Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
7 batches manufactured by Mercury Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality in October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: M24097, Calcium Carbonate & Vitamin D3 Tablets (TISE-CAL) (exp Feb 2026). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per IP 2022 With respect to Assay. Listed in the October 2025 alert.
Records by type
7 records linked to Mercury Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Calcium Carbonate & Vitamin D3 Tablets (TISE-CAL) | Batch M24097Mfg Sep 2024 · Exp Feb 2026 | The sample does not conform to claim as per IP 2022 With respect to AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
| Calcium Carbonate & Vitamin D3 Tablets (TISE-CAL) | Batch M24120Mfg Nov 2024 · Exp Apr 2026 | The sample does not conform to claim as per IP 2022 With respect to AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
| Calcium Carbonate & Vitamin D3 Tablets (TISE-CAL) | Batch M24099Mfg Sep 2024 · Exp Feb 2026 | The sample does not conform to claim as per IP 2022 With respect to AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
| Calcium & Vitamin D3 Tablets (TISE-CAL) | Batch M24122Mfg Nov 2024 · Exp Apr 2026 | The sample does not conform to claim as per IP 2022 with respect to AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
| Calcium & Vitamin D3 Tablets (TISE-CAL) | Batch M24119Mfg Nov 2024 · Exp Apr 2026 | The sample does not conform to claim as per IP 2022 with respect to AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
| Calcium & Vitamin D3 Tablets (TISE-CAL) | Batch M24098Mfg Sep 2024 · Exp Feb 2026 | The sample does not conform to claim as per IP 2022 with respect to AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
| Calcium & Vitamin D3 Tablets (TISE-CAL) | Batch M24121Mfg Nov 2024 · Exp Apr 2026 | The sample does not conform to claim as per IP 2022 with respect to AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.